Electrophilically activated nitroalkanes in the synthesis of substituted 1,3,4-oxadiazoles from amino acid derivatives

[1]  A. Aksenov,et al.  Electrophilically Activated Nitroalkanes in Synthesis of 3,4-Dihydroquinozalines , 2021, Molecules.

[2]  Anil Kumar,et al.  Indolyl-α-keto-1,3,4-oxadiazoles: synthesis, anti-cell proliferation activity, and inhibition of tubulin polymerization. , 2021, Bioorganic & medicinal chemistry letters.

[3]  Ankur Vaidya,et al.  1,3,4‐oxadiazole and its derivatives: A review on recent progress in anticancer activities , 2020, Chemical biology & drug design.

[4]  A. Aksenov,et al.  Preparation of 1,3,4-oxadiazoles and 1,3,4-thiadiazoles via chemoselective сyclocondensation of electrophilically activated nitroalkanes to (thio)semicarbazides or thiohydrazides , 2020, Chemistry of Heterocyclic Compounds.

[5]  Joginder Singh,et al.  Synthesis, Characterization, Antimicrobial, Anti-tubercular, Antioxidant Activities and Docking Simulations of Derivatives of 2-(pyridin-3-yl)-1Hbenzo[ d]imidazole and 1,3,4-Oxadiazole Analogy , 2020 .

[6]  Simone Brogi,et al.  ( S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic Acid (AMPA) and Kainate Receptor Ligands: Further Exploration of Bioisosteric Replacements and Structural and Biological Investigation. , 2018, Journal of medicinal chemistry.

[7]  V. Khedkar,et al.  Synthesis, biological evaluation, and molecular docking study of pyridine clubbed 1,3,4-oxadiazoles as potential antituberculars , 2018 .

[8]  R. Khanam,et al.  Inhibitory growth evaluation and apoptosis induction in MCF-7 cancer cells by new 5-aryl-2-butylthio-1,3,4-oxadiazole derivatives , 2017, Cancer Chemotherapy and Pharmacology.

[9]  G. Klebe,et al.  Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin: Fragment‐Based Drug Design Facilitated by Dynamic Combinatorial Chemistry , 2016, Angewandte Chemie.

[10]  A. Kudelko,et al.  An efficient synthesis of conjugated 5-aryl-1,3,4-oxadiazoles from 3-heteroarylacrylohydrazides and acid chlorides , 2014 .

[11]  K. Mohana,et al.  Synthesis and in vitro antiproliferative activity of 2,5-disubstituted-1,3,4-oxadiazoles containing trifluoromethyl benzenesulfonamide moiety , 2014, Medicinal Chemistry Research.

[12]  Jigar A. Makawana,et al.  1,3,4-oxadiazole derivatives as potential biological agents. , 2013, Mini reviews in medicinal chemistry.

[13]  K. Shah,et al.  Synthesis and Biological Evaluation of 2‐Arylamino‐5‐ (3′‐Indolyl)‐1,3,4‐Oxadiazoles as Potent Cytotoxic Agents , 2013, ChemMedChem.

[14]  C. Kavitha,et al.  Synthesis and evaluation of 2,5-di(4-aryloylaryloxymethyl)-1,3,4-oxadiazoles as anti-cancer agents. , 2013, European journal of medicinal chemistry.

[15]  Tack-Joong Kim,et al.  Syntheses and anti-allergic activity of 2-((bis(trimethylsilyl)methylthio/methylsulfonyl)methyl)-5-aryl-1,3,4-oxadiazoles. , 2013, European journal of medicinal chemistry.

[16]  H. Stoeckli-Evans,et al.  Synthesis, Crystal Structure and Anti-HIV Activity of 2- Adamantyl/adamantylmethyl-5-aryl-1,3,4-oxadiazoles , 2012 .

[17]  Tack-Joong Kim,et al.  Antiallergic activity profile in vitro RBL-2H3 and in vivo passive cutaneous anaphylaxis mouse model of new sila-substituted 1,3,4-oxadiazoles. , 2012, Journal of medicinal chemistry.

[18]  B. Ahmed,et al.  1,3,4-oxadiazole: a biologically active scaffold. , 2012, Mini reviews in medicinal chemistry.

[19]  K. Ejsmont,et al.  The reaction of optically active α-aminocarboxylic acid hydrazides with triethyl orthoesters , 2011 .

[20]  S. Hameed,et al.  Synthesis, QSAR and anti-HIV activity of new 5-benzylthio-1,3,4-oxadiazoles derived from α-amino acids , 2011, Journal of enzyme inhibition and medicinal chemistry.

[21]  I. V. Aksenova,et al.  Nitroethane in PolyphosphoricAcid: A New Reagent for Acetamidation and Amination of AromaticCompounds , 2010 .

[22]  R. Loddo,et al.  Synthesis and in vitro antiproliferative activity of new adamantylthiazolyl-1,3,4-oxadiazoles , 2009 .

[23]  W. Schleif,et al.  P1' oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1. , 2004, Bioorganic & medicinal chemistry letters.

[24]  M. Shalaby,et al.  Polysubstituted pyrazoles, part 5. Synthesis of new 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazole-3-carboxylic acid hydrazide analogs and some derived ring systems. A novel class of potential antitumor and anti-HCV agents. , 2003, European journal of medicinal chemistry.